Literature DB >> 16415037

Identification and characterization of two internal cleavage and polyadenylation sites of parvovirus B19 RNA.

Yuko Yoto1, Jianming Qiu, David J Pintel.   

Abstract

Polyadenylation of B19 pre-mRNAs at the major internal site, (pA)p1, is programmed by the nonconsensus core cleavage and polyadenylation specificity factor-binding hexanucleotide AUUAAA. Efficient use of this element requires both downstream and upstream cis-acting elements and is further influenced by an adjacent AAUAAC motif. The primary hexanucleotide element must be nonconsensus to allow efficient readthrough of P6-generated pre-mRNAs into the capsid-coding region. An additional cleavage and polyadenylation site, (pA)p2, 296 nucleotides downstream of (pA)p1 was shown to be used following both B19 infection and transfection of a genomic clone. RNAs polyadenylated at (pA)p2 comprise approximately 10% of B19 RNAs that are polyadenylated internally.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415037      PMCID: PMC1346959          DOI: 10.1128/JVI.80.3.1604-1609.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

Review 1.  Parvovirus B19.

Authors:  Neal S Young; Kevin E Brown
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

2.  Accumulation of MVM gene products is differentially regulated by transcription initiation, RNA processing and protein stability.

Authors:  R V Schoborg; D J Pintel
Journal:  Virology       Date:  1991-03       Impact factor: 3.616

3.  Analysis of splice junctions and in vitro and in vivo translation potential of the small, abundant B19 parvovirus RNAs.

Authors:  J St Amand; C Beard; K Humphries; C R Astell
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

4.  Human parvovirus B19 induces cell cycle arrest at G(2) phase with accumulation of mitotic cyclins.

Authors:  E Morita; K Tada; H Chisaka; H Asao; H Sato; N Yaegashi; K Sugamura
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Detailed transcription map of Aleutian mink disease parvovirus.

Authors:  S Alexandersen; M E Bloom; S Perryman
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

6.  Transient expression of B19 parvovirus gene products in COS-7 cells transfected with B19-SV40 hybrid vectors.

Authors:  C Beard; J St Amand; C R Astell
Journal:  Virology       Date:  1989-10       Impact factor: 3.616

7.  The expression strategy of goose parvovirus exhibits features of both the Dependovirus and Parvovirus genera.

Authors:  Jianming Qiu; Fang Cheng; Yuko Yoto; Zoltán Zádori; David Pintel
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Construction and sequencing of an infectious clone of the human parvovirus B19.

Authors:  Ning Zhi; Zoltán Zádori; Kevin E Brown; Peter Tijssen
Journal:  Virology       Date:  2004-01-05       Impact factor: 3.616

9.  Novel transcription map for the B19 (human) pathogenic parvovirus.

Authors:  K Ozawa; J Ayub; Y S Hao; G Kurtzman; T Shimada; N Young
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

10.  Splice junction map of simian parvovirus transcripts.

Authors:  Kapil Vashisht; Kay S Faaberg; Amanda L Aber; Kevin E Brown; M Gerard O'Sullivan
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more
  19 in total

1.  Efficient expression of the adeno-associated virus type 5 p41 capsid gene promoter in 293 cells does not require Rep.

Authors:  Chaoyang Ye; Jianming Qiu; David J Pintel
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.

Authors:  Anna Ekman; Kati Hokynar; Laura Kakkola; Kalle Kantola; Lea Hedman; Heidi Bondén; Matthias Gessner; Claudia Aberham; Päivi Norja; Simo Miettinen; Klaus Hedman; Maria Söderlund-Venermo
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

3.  Block to the production of full-length B19 virus transcripts by internal polyadenylation is overcome by replication of the viral genome.

Authors:  Wuxiang Guan; Fang Cheng; Yuko Yoto; Steve Kleiboeker; Susan Wong; Ning Zhi; David J Pintel; Jianming Qiu
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

4.  Molecular characterization of human parvovirus B19 genotypes 2 and 3.

Authors:  Zhaojun Chen; Wuxiang Guan; Fang Cheng; Aaron Yun Chen; Jianming Qiu
Journal:  Virology       Date:  2009-09-15       Impact factor: 3.616

5.  The Human Bocavirus 1 NP1 Protein Is a Multifunctional Regulator of Viral RNA Processing.

Authors:  Yanming Dong; Olufemi O Fasina; David J Pintel
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

6.  RNA Binding Protein RBM38 Regulates Expression of the 11-Kilodalton Protein of Parvovirus B19, Which Facilitates Viral DNA Replication.

Authors:  Safder S Ganaie; Aaron Yun Chen; Chun Huang; Peng Xu; Steve Kleiboeker; Aifang Du; Jianming Qiu
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

7.  Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells.

Authors:  Aaron Yun Chen; Wuxiang Guan; Sai Lou; Zhengwen Liu; Steve Kleiboeker; Jianming Qiu
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

8.  Internal polyadenylation of the parvovirus B19 precursor mRNA is regulated by alternative splicing.

Authors:  Wuxiang Guan; Qinfeng Huang; Fang Cheng; Jianming Qiu
Journal:  J Biol Chem       Date:  2011-05-27       Impact factor: 5.157

9.  Inclusion of the central exon of parvovirus B19 precursor mRNA is determined by multiple splicing enhancers in both the exon and the downstream intron.

Authors:  Wuxiang Guan; Fang Cheng; Qinfeng Huang; Steve Kleiboeker; Jianming Qiu
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

10.  NP1 Protein of the Bocaparvovirus Minute Virus of Canines Controls Access to the Viral Capsid Genes via Its Role in RNA Processing.

Authors:  Olufemi O Fasina; Yanming Dong; David J Pintel
Journal:  J Virol       Date:  2015-12-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.